These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24000114)

  • 1. Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.
    Du C; Hong R; Shi Y; Yu X; Wang J
    J Neurooncol; 2013 Nov; 115(2):285-91. PubMed ID: 24000114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
    Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
    Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
    Nakagawa K; Takano K; Nishino K; Ohe S; Nakayama T; Arita H
    J Neurooncol; 2024 May; 167(3):397-406. PubMed ID: 38430420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
    Waki F; Ando M; Takashima A; Yonemori K; Nokihara H; Miyake M; Tateishi U; Tsuta K; Shimada Y; Fujiwara Y; Tamura T
    J Neurooncol; 2009 Jun; 93(2):205-12. PubMed ID: 19043775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
    Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors.
    Kwon J; Chie EK; Kim K; Kim HJ; Wu HG; Kim IH; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ; Ha SW
    J Korean Med Sci; 2014 Aug; 29(8):1094-101. PubMed ID: 25120319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.
    Huang S; Kang X; Wang C; Zhang W; Jiang J; Kang Z; Yang S; Chen J; Chen F; Li W
    J Cancer Res Ther; 2024 Apr; 20(2):658-664. PubMed ID: 38687937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.
    Devecka M; Duma MN; Wilkens JJ; Kampfer S; Borm KJ; Münch S; Straube C; Combs SE
    BMC Cancer; 2020 Jun; 20(1):501. PubMed ID: 32487151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidermal growth factor tyrosine kinase inhibitors used in the treatment of NSCLC patients with leptomeningeal metastasis].
    Xu Y; Zhong W; Zhao J; Chen MJ; Zhang L; Li LY; Wang MZ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):920-924. PubMed ID: 27998469
    [No Abstract]   [Full Text] [Related]  

  • 12. Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations.
    Lee S; Ahn HK; Park YH; Nam DH; Lee JI; Park W; Choi DH; Huh SJ; Park KT; Ahn JS; Im YH
    Breast Cancer Res Treat; 2011 Oct; 129(3):809-17. PubMed ID: 21785952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal metastases in the MRI era.
    Clarke JL; Perez HR; Jacks LM; Panageas KS; Deangelis LM
    Neurology; 2010 May; 74(18):1449-54. PubMed ID: 20439847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
    Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
    J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
    Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.
    Choi M; Keam B; Ock CY; Kim M; Kim TM; Kim DW; Heo DS
    Clin Lung Cancer; 2019 Jul; 20(4):e442-e451. PubMed ID: 31010639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer.
    Wu YL; Zhao Q; Deng L; Zhang Y; Zhou XJ; Li YY; Yu M; Zhou L; Zou BW; Lu Y; Liu YM
    Lung Cancer; 2019 Jan; 127():1-5. PubMed ID: 30642536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
    Morris PG; Reiner AS; Szenberg OR; Clarke JL; Panageas KS; Perez HR; Kris MG; Chan TA; DeAngelis LM; Omuro AM
    J Thorac Oncol; 2012 Feb; 7(2):382-5. PubMed ID: 22089116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.